TPCW
NVAX icon

TD Private Client Wealth’s Novavax NVAX Stock Holding History

TD Private Client Wealth’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3
Closed -$429 – 1310
2021
Q4 		$429 Sell
3
-6
-67% -$1.03K ﹤0.01% 1143
2021
Q3 		$1.87K Sell
9
-3
-25% -$661 ﹤0.01% 1044
2021
Q2 		$2.55K Buy
+12
New +$2.2K ﹤0.01% 1017

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TD Private Client Wealth's NVAX Position: Q1 2022 in Review

TD Private Client Wealth sold out of Novavax (NVAX) in Q1 2022, closing a stake of 3 shares — an estimated $429 sold.

TD Private Client Wealth first reported a position in NVAX in Q2 2021 and held it in 3 quarters. The position peaked at $2.55K in Q2 2021. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

  • TD Private Client Wealth reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
  • TD Private Client Wealth sold 3 Novavax shares in Q1 2022, an estimated $429.
  • TD Private Client Wealth first reported a position in Novavax in Q2 2021 and held it in 3 quarters.
  • TD Private Client Wealth's Novavax position peaked at $2.55K in Q2 2021.
  • 381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on TD Private Client Wealth's 13F filing for Q1 2022, filed 16 Aug 2024.